The aim of this study was to evaluate PD-L1 expression on tumour cells and immune cells using three scoring methods (TPS, IC, and CPS) and to analyse the relationship of these results with TME and the possible prognosis of early-stage NSCLC patients who underwent surgical resection. This evidence concerns the gene CD274 and non-small cell lung carcinoma.